Nalaganje...

Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation

BACKGROUND: Dabigatran, an oral thrombin inhibitor, and rivaroxaban and apixaban, oral factor Xa inhibitors, have been found safe and effective in reducing stroke risk in patients with atrial fibrillation. We sought to compare the efficacy and safety of the 3 new agents based on data from their publ...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Schneeweiss, Sebastian, Gagne, Joshua J, Patrick, Amanda R, Choudhry, Niteesh K, Avorn, Jerry
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3471365/
https://ncbi.nlm.nih.gov/pubmed/22787066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.112.965988
Oznake: Označite
Brez oznak, prvi označite!